Headlines
Germany's Brainlab puts IPO on hold
Published by Global Banking & Finance Review®
Posted on July 1, 2025
2 min readLast updated: January 23, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on July 1, 2025
2 min readLast updated: January 23, 2026
Germany's Brainlab postpones its IPO amid volatile markets, impacting its valuation and listing plans on the Frankfurt Stock Exchange.
BERLIN (Reuters) -German medical technology firm Brainlab on Tuesday became the latest IPO candidate in the region to put listing plans on hold amid volatile stock markets over recent months.
Brainlab, a Munich-based maker of imaging and guidance software for surgeons, said in a brief statement that it and the selling shareholders decided to postpone the planned IPO, without citing a reason.
It had previously eyed a price of 80 euros ($94) per share, the lower end of a previous offer range, for its planned initial public offering with the first day of trading scheduled for Thursday.
"An IPO at a later time remains under consideration by Brainlab and the selling shareholders," a statement from the company said.
The listing on the Frankfurt Stock Exchange would have been the first major IPO this year for Germany.
Several European companies have pulled listing plans so far this year amid growing investor uncertainty from global trade wars and military conflicts. German car parts seller Autodoc put IPO plans on hold last month.
The planned sale of Brainlab shares worth 416 million euros, both existing and new ones, would have valued all of its equity capital at close to 1.7 billion euros.
($1 = 0.8523 euros)
(Reporting by Ludwig Burger; editing by Matthias Williams and Miranda Murray)
Brainlab decided to postpone its planned IPO due to the volatile stock markets in recent months, although no specific reason was cited.
Brainlab had previously aimed for a price of 80 euros ($94) per share for its initial public offering.
The postponement of Brainlab's IPO marks a significant moment as it would have been the first major IPO this year for Germany, highlighting the current investor uncertainty.
The planned sale of Brainlab shares was worth 416 million euros, which would have valued the company's equity capital at close to 1.7 billion euros.
Several European companies, including German car parts seller Autodoc, have also pulled their listing plans amid growing investor uncertainty from global trade wars and military conflicts.
Explore more articles in the Headlines category
